Rieneke T. Lugtenberg

Learn More
BACKGROUND Survival data of malignant rhabdoid tumour of the kidney (MRTK) registered in SIOP trials, advocating preoperative chemotherapy, are not available. AIM To evaluate characteristics, response and survival of MRTK patients registered in recent SIOP protocols. METHODS An evaluation of all MRTK patients treated from 1993 to 2005 (SIOP trials 93-01(More)
The therapeutic strategy for bilateral Wilms tumor (WT) remains a challenge. Especially in cases with chemotherapy resistant disease, bilateral nephrectomy is sometimes inevitable. For optimal cure rates stage V WT patients benefit from adjuvant treatment; however, there are limited data available on chemotherapy pharmacokinetics in anephric children. In(More)
  • 1